Pages that link to "Q36157982"
Jump to navigation
Jump to search
The following pages link to Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression. (Q36157982):
Displaying 50 items.
- Autophagy-associated immune responses and cancer immunotherapy (Q26770690) (← links)
- Biomarkers for glioma immunotherapy: the next generation (Q26825496) (← links)
- Pathways and therapeutic targets in melanoma (Q26865736) (← links)
- You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia (Q26998971) (← links)
- Autophagy in cancer (Q26999216) (← links)
- PAMPs and DAMPs: signal 0s that spur autophagy and immunity (Q27004190) (← links)
- Targeting mitochondrial metabolism by inhibiting autophagy in BRAF-driven cancers (Q27022240) (← links)
- Therapeutic Targeting of Autophagy (Q28078117) (← links)
- Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy? (Q30584653) (← links)
- The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells (Q33709243) (← links)
- New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targets (Q33731804) (← links)
- Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy (Q33839054) (← links)
- Damage associated molecular pattern molecule-induced microRNAs (DAMPmiRs) in human peripheral blood mononuclear cells (Q34321166) (← links)
- Mechanisms and applications of interleukins in cancer immunotherapy (Q34458290) (← links)
- Novel adjuvants from seaweed impede autophagy signaling in therapy-resistant residual pancreatic cancer (Q35521264) (← links)
- Yet another function of p53--the switch that determines whether radiation-induced autophagy will be cytoprotective or nonprotective: implications for autophagy inhibition as a therapeutic strategy (Q35531849) (← links)
- Autophagy in pancreatic cancer pathogenesis and treatment (Q36135812) (← links)
- Autophagy is associated with chemoresistance in neuroblastoma (Q36193465) (← links)
- Autophagy is required for IL-2-mediated fibroblast growth (Q36585665) (← links)
- Localized immunotherapy via liposome-anchored Anti-CD137 + IL-2 prevents lethal toxicity and elicits local and systemic antitumor immunity. (Q36675055) (← links)
- Common γ-chain cytokine signaling is required for macroautophagy induction during CD4+ T-cell activation (Q36777212) (← links)
- Chloroquine enhanced the anticancer capacity of VNP20009 by inhibiting autophagy (Q37093323) (← links)
- The multifaceted role of autophagy in tumor evasion from immune surveillance (Q37109549) (← links)
- Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment (Q37299613) (← links)
- TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation (Q37682407) (← links)
- Autophagy: A novel therapeutic target for hepatocarcinoma (Review). (Q37720015) (← links)
- Pathogen-induced autophagy signaling in innate immunity. (Q38104885) (← links)
- Autophagy and transporter-based multi-drug resistance (Q38202874) (← links)
- HMGB1 in hormone-related cancer: a potential therapeutic target (Q38203471) (← links)
- Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects (Q38689955) (← links)
- Glucose-independent Acetate Metabolism Promotes Melanoma Cell Survival and Tumor Growth (Q38751146) (← links)
- Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy (Q38795278) (← links)
- Biological Response Modifier in Cancer Immunotherapy (Q38848213) (← links)
- The plasma membrane sialidase NEU3 regulates the malignancy of renal carcinoma cells by controlling β1 integrin internalization and recycling (Q39247356) (← links)
- Cell-mediated autophagy promotes cancer cell survival. (Q39364287) (← links)
- Perpetual change: autophagy, the endothelium, and response to vascular injury (Q39381435) (← links)
- Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2. (Q39699164) (← links)
- Chloroquine anticancer activity is mediated by autophagy-independent effects on the tumor vasculature (Q40632489) (← links)
- Chloroquine promotes apoptosis in melanoma cells by inhibiting BH3 domain-mediated PUMA degradation (Q41842617) (← links)
- Targeting autophagy in cancer (Q41912265) (← links)
- Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents. (Q47162451) (← links)
- AKAP200 promotes Notch stability by protecting it from Cbl/lysosome-mediated degradation in Drosophila melanogaster. (Q47198403) (← links)
- Defining the role of the tumor vasculature in antitumor immunity and immunotherapy (Q49679692) (← links)
- Targeting Autophagy in the Tumor Microenvironment: New Challenges and Opportunities for Regulating Tumor Immunity. (Q55260560) (← links)
- Peptides/Proteins Encoded by Non-coding RNA: A Novel Resource Bank for Drug Targets and Biomarkers (Q59329225) (← links)
- Modulating T Cell Responses via Autophagy: The Intrinsic Influence Controlling the Function of Both Antigen-Presenting Cells and T Cells (Q60954864) (← links)
- The relationship between autophagy and the immune system and its applications for tumor immunotherapy (Q61444104) (← links)
- An ATP-Regulated Ion Transport Nanosystem for Homeostatic Perturbation Therapy and Sensitizing Photodynamic Therapy by Autophagy Inhibition of Tumors (Q64234443) (← links)
- The Multifaceted Effects of Autophagy on the Tumor Microenvironment (Q89587163) (← links)
- Reticular Dysgenesis and Mitochondriopathy Induced by Adenylate Kinase 2 Deficiency with Atypical Presentation (Q91045412) (← links)